EMA tests electronic forms for submitting drug marketing applications
This article was originally published in Scrip
Executive Summary
The European Medicines Agency has invited pharmaceutical companies to take part in a four-month pilot programme that will allow them to use new interactive PDF forms to submit marketing authorisation applications via the EU's centralised procedure. The pilot, which can also be used to submit applications to make changes to marketing authorisations or to renew authorisations, was launched on 12 March and will run until mid-July.